Many people are familiar with histamine, a biological molecule that serves as a key driver of allergic reactions and other ...
Morning Overview on MSN
Scientists watch drug molecules hit cell receptors in real time
Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...
Many people are familiar with histamine, a biological molecule, that serves as a key driver of allergic reactions and other immune responses. However ...
A research team of the University Medical Center Mainz has succeeded in observing for the first time how G protein-coupled ...
Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...
Structure Therapeutics Inc. (NASDAQ: GPCR) is among the 14 best booming stocks to buy right now. The company’s shares have ...
InterAx Biotech Ltd ("InterAx") and Alveus Therapeutics Inc. ("Alveus") today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate ...
The Phase II segment is a randomised, double-blind, placebo-controlled study assessing ABCL635 efficacy in 80 postmenopausal ...
4d
Coherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...
Live Updates Get The Best AMD Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on AMD, ...
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies -- Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback